Gene · 572
Papers1,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The protective effect of rutin against the cisplatin-induced cochlear damage in vitro. | Neurotoxicology | 2022 | 35304134 | PubTator, text mining | PubMed |
| Specific interactions of peripheral membrane proteins with lipids: what can molecular simulations show us? | Biosci Rep | 2022 | 35297484 | PubTator, text mining | PubMed |
| Short-Term Adaptations in Skeletal Muscle Mitochondrial Oxidative Capacity and Metabolic Pathways to Breaking up Sedentary Behaviors in Overweight or Obese Adults. | Nutrients | 2022 | 35276813 | PubTator, text mining | PubMed |
| Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway. | Arch Toxicol | 2022 | 35267068 | PubTator, text mining | PubMed |
| BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer. | Sci Rep | 2022 | 35260587 | PubTator, text mining | PubMed |
| Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review. | Drug Des Devel Ther | 2022 | 35256842 | PubTator, text mining | PubMed |
| Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy Loss. | Endocrinology | 2022 | 35255139 | PubTator, text mining | PubMed |
| Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells. | Front Cell Dev Biol | 2022 | 35237605 | PubTator, text mining | PubMed |
| MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3-phospho-BAD pathway. | Cell Death Discov | 2022 | 35217648 | PubTator, text mining | PubMed |
| Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. | Int J Mol Sci | 2022 | 35216449 | PubTator, text mining | PubMed |
| Male Infertility and Oxidative Stress: A Focus on the Underlying Mechanisms. | Antioxidants (Basel) | 2022 | 35204189 | PubTator, text mining | PubMed |
| Helicid Improves Lipopolysaccharide-Induced Apoptosis of C6 Cells by Regulating SH2D5 DNA Methylation via the CytC/Caspase9/Caspase3 Signaling Pathway. | Contrast Media Mol Imaging | 2022 | 35173561 | PubTator, text mining | PubMed |
| Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. | Environ Sci Pollut Res Int | 2022 | 35171422 | PubTator, text mining | PubMed |
| The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. | Transl Oncol | 2022 | 35168143 | PubTator, text mining | PubMed |
| Novel genetic sex markers reveal unexpected lack of, and similar susceptibility to, sex reversal in free-living common toads in both natural and anthropogenic habitats. | Mol Ecol | 2022 | 35146823 | PubTator, text mining | PubMed |
| Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress. | Stem Cell Res Ther | 2022 | 35093187 | PubTator, text mining | PubMed |
| Updated Austrian treatment algorithm in HER2+ metastatic breast cancer. | Wien Klin Wochenschr | 2022 | 35089396 | PubTator, text mining | PubMed |
| BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. | Pharmaceutics | 2022 | 35057108 | PubTator, text mining | PubMed |
| Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma. | Int J Mol Sci | 2022 | 35055167 | PubTator, text mining | PubMed |
| The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications. | Biomolecules | 2022 | 35053275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/572/papers?page=10